Evidence mapPaperPMID 37530949Full record

ReviewInfectious diseases and therapy2023

Herpes Zoster Burden of Disease and Clinical Management in Turkey: A Comprehensive Literature Review.

Selim Badur, Esin Senol, Alpay Azap, Cihan Yesiloglu, Alev Ozakay, Serdar Ozturk, Adriana Guzman-Holst

Abstract readReview
In one paragraph

Review in Infectious diseases and therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Selim BadurGSK, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-0490-7203
Esin SenolGazi University, Ankara, Turkey.ORCID http://orcid.org/0000-0003-1535-2757
Alpay AzapAnkara University, Ankara, Turkey.ORCID http://orcid.org/0000-0001-5035-055X
Cihan YesilogluGSK, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-1972-2738
Alev OzakayGSK, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-6227-239X
Serdar OzturkGSK, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-5885-6173
Adriana Guzman-HolstGSK Vaccines, 20 Avenue Fleming, 1300, Wavre, Belgium. adriana.x.guzman@gsk.com.ORCID http://orcid.org/0000-0002-6753-2541

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHerpes zoster (HZ), or shingles, is caused by the reactivation of varicella zoster virus (VZV) and typically presents as an acute, painful dermatomal rash, but can lead to long-term, distressing complications such as postherpetic neuralgia (PHN). Increasing trends in HZ cases are evident globally among the aging population; however, reviews investigating the epidemiology and clinical management of HZ in Turkey are lacking. Therefore, a literature review of local studies in Turkey was conducted to identify the data available and identify gaps in the literature.

methodsLiterature searches were carried out in PubMed and local journals to retrieve published articles that reported surveillance data, seroepidemiology, patient outcomes, or clinical management related to HZ or VZV in Turkey until April 30, 2022. Studies included primary data reports, case studies, secondary data reviews, and epidemiological studies in healthy or at-risk populations; HZ was the primary focus of the review.

resultsNo studies reported VZV or HZ epidemiological data at a national level. One large retrospective study in Istanbul reported that HZ incidence rates significantly increased in adults 18-44 years of age between 2011 and 2019. Four single-center studies reported the proportion of dermatological patients with HZ at 0.43-1.56%. PHN was the most common reported complication, occurring in 8-58.9% of patients with HZ. However, out of 39 identified case reports, HZ ophthalmicus was the most frequently reported complication. Two studies highlighted poor disease awareness and risk perception of HZ among Turkish citizens.

conclusionOverall, there were limited comprehensive epidemiological data on HZ in Turkey. However, the abundance of case studies on HZ complications indicates a strong disease presence and diverse clinical management in Turkey. Further research will be important to understand the impact of HZ, increase disease awareness, and support the introduction of new preventative strategies.

Indexed as

ChickenpoxHerpes zosterShinglesTurkeyVaricella zoster virus

Identifiers

PMID37530949
PMCPMC10505134

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.